Robert Lutz - Mar 10, 2022 Form 4 Insider Report for iBio, Inc. (IBIO)

Role: Chief Financial & Business Officer and Principal Financial and Accounting Officer
Signature: /s/Robert Matthew Lutz
Stock symbol: IBIO
Transactions as of: Mar 10, 2022
Transactions value $: -$8,510
Form type: 4
Date filed: 3/14/2022, 04:12 PM
Previous filing: Aug 25, 2021
Next filing: Aug 31, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IBIO	Common Stock	Sale	-$8.51K	-24.6K	-10.61%	$0.35	207K	Mar 10, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3410 to $0.3481 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3410 to $0.3481 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

Chief Financial & Business Officer and Principal Financial and Accounting Officer